TREM2 and early-onset autosomal dominant Alzheimer disease: In mouse models of Alzheimer’s disease, enhancement of Trem2 signaling using agonistic antibodies has recently shown beneficial effects on cognitive function through attenuation of neuroinflammation and improved plaque clearance within the brain (60, 61).